How to Spot a Fake Mounjaro or Ozempic Pen Before You Inject It

Why Counterfeit GLP-1 Pens Are a Growing UK Problem

When the demand for a medicine outpaces legitimate supply, a predictable shadow market develops. Mounjaro and Ozempic have been subject to supply constraints across multiple periods since their weight-management applications gained traction, and that scarcity has driven significant numbers of patients toward online sellers, social media platforms, and grey-market sources. Counterfeit pens now circulate widely enough that the MHRA has issued multiple public warnings and conducted seizures involving fake GLP-1 products.

The danger is not hypothetical. Analysed counterfeit pens intercepted in the UK have contained contents ranging from water to unknown substances to insulin, and at incorrect concentrations. A patient who injects insulin believing they are taking semaglutide can experience life-threatening hypoglycaemia, particularly if they are not diabetic. The pens themselves are often sophisticated enough that a brief visual inspection is not sufficient.

What a Genuine Mounjaro Pen Looks Like

Genuine Mounjaro (tirzepatide) pens are manufactured by Eli Lilly. The autoinjector has a distinctive design: a smooth, cylindrical body with a defined colour coding by dose: each strength has a designated pen colour, and those colours are consistent across all legitimate supply. The label is printed directly onto the device, not applied as a sticker, and the text is crisp with no blurring or misalignment. The cap fits firmly with a slight resistance when removed.

The viewing window — a small clear section on the body of the pen — should show a colourless to slightly yellow solution that is clear and free from particles. Any cloudiness, visible debris, or discolouration is a cause for concern. The KwikPen mechanism delivers an audible and tactile click when the dose is confirmed, and that click should feel consistent and definite.

Packaging for genuine Mounjaro includes a carton with specific lot number formatting, an expiry date that is not smudged or reprinted, and an enclosed patient information leaflet that matches the device exactly. Genuine packaging uses specific fonts and layout specifications that counterfeit operations often render imprecisely.

What a Genuine Ozempic Pen Looks Like

Genuine Ozempic (semaglutide) pens are manufactured by Novo Nordisk. The FlexTouch pen is a pre-filled, multi-dose device with a body in a specific shade of blue, a dose selector, and a dose counter window. The dose counter should show a number, not a blank, and the numbers should be printed cleanly. The needle hub connects to a standard Novo Nordisk needle, not an unusual proprietary fitting.

The solution in an Ozempic pen is colourless to slightly yellow and should be transparent. The pen carries specific lot number and expiry information that can be cross-referenced with Novo Nordisk's pharmacovigilance guidance. As with Mounjaro, the secondary packaging contains a precisely formatted patient information leaflet, and that leaflet should match the regulatory text filed for the product.

For a more granular visual breakdown, the counterfeit Mounjaro pen identification guide includes photograph-referenced comparisons of confirmed genuine and seized counterfeit devices.

Five Physical Checks Anyone Can Perform Before Injecting

These checks take under two minutes and should be performed each time a new pen is used, regardless of source.

First, examine the outer carton before opening it. Genuine manufacturers use clean, press-printed graphics with consistent fonts, specific regulatory markings, and correctly formatted lot numbers. Blurred print, inconsistent colours, missing regulatory text, or lot numbers that are hand-stamped rather than machine-printed are warning signs.

Second, inspect the label on the pen body itself. It should be smooth, flush with the surface, and printed with consistent ink density. Sticker labels that can be partially lifted or that show an edge raised away from the pen body are inconsistent with genuine manufacturer production.

Third, assess the solution through the viewing window. It should be clear. Turbid, particulate-containing, or unusually coloured solutions should not be injected. If you cannot see a viewing window on a pen that is supposed to have one, treat the device as suspect.

Fourth, test the cap and mechanism. The cap of a genuine pen has a controlled resistance: firm but removable without excessive force. Mechanisms that feel loose, rattle, or deliver an inconsistent or absent click when actuated are not consistent with authenticated devices.

Fifth, verify the source. A genuine pen should trace directly to a GPhC-registered UK pharmacy dispensing against a valid UK prescription. If you cannot establish that chain, the preceding physical checks become even more important, and the threshold for not injecting should be lower.

Social Media and Marketplace Seller Patterns to Avoid

The most consistent source of counterfeit GLP-1 pens in current UK seizure data is social media sellers and online marketplaces. These sellers typically operate through Instagram, Facebook Marketplace, WhatsApp groups, and secondary-market platforms. They frequently claim to be offering genuine product obtained from abroad, or excess prescription supply, or clinic overstock.

None of these justifications produces a legally obtained, quality-guaranteed product. A prescription medicine sold outside the regulated pharmacy supply chain cannot be authenticated regardless of what the seller claims. Sellers on these platforms cannot provide a dispensing record, cannot be held to GPhC standards, and disappear when problems emerge.

The price-as-quality signal reversal also applies here: pens offered at substantial discounts to legitimate UK pharmacy prices should raise suspicion immediately, not function as an incentive.

What to Do If Your Pen Looks Wrong or You Have Already Injected

If a physical inspection of a pen raises concerns before injection, do not use it. Keep the device and its packaging: they will be needed if you report it. Contact the MHRA directly via the Yellow Card system and, if possible, retain a photograph of the concerning features.

If you have already injected from a pen that you subsequently suspect was counterfeit, seek urgent medical assessment. Tell the clinician that you may have injected an unknown substance and bring the pen with you. The most serious acute risk is hypoglycaemia from an insulin-containing counterfeit, but other contaminants create infection and toxic exposure risks that warrant clinical evaluation.

How to Report a Suspected Counterfeit to the MHRA via Yellow Card

The Yellow Card system accepts reports from patients and healthcare professionals regarding suspected substandard or counterfeit medicines as well as adverse drug reactions. A report about a suspect pen should include the product name, the lot number and expiry date where visible, the source of the product (even if that source was a social media seller), and a description of the features that raised concern.

Understanding how to file a Yellow Card report for a suspect medicine takes less time than most patients expect. Reports submitted by patients are reviewed by MHRA assessors and can trigger market surveillance activity, seizures, or public safety alerts, so even a single report from a well-documented case carries genuine public health value.

The fundamental protection against this risk, however, is not downstream reporting. It is only ever obtaining GLP-1 medicines through a GPhC-registered pharmacy dispensing against a valid UK prescription. Every other route creates a verification problem that no amount of physical inspection can fully resolve.